Publikationen 2017

Zeitschriftenbeiträge (nach Erscheinungsdatum)

Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, Holleczek B, Katalinic A, Luttmann S, Sundquist K, Ressing M, Xu L, Hemminki K; GEKID Cancer Survival Working Group. Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries. Int J Cancer. 2017, 141(11):2270-2280

Weberpals J, Pulte D, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Merz M, Brenner H; GEKID Cancer Survival Working Group. Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21st century. Haematologica 2017, 102(6):e229-e232

Doege D, Thong M, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Waldeyer-Sauerland M, Waldmann A, Zeissig SR, Brenner H, Arndt V. The role of psychosocial resources for long-term breast, colorectal and prostate cancer survivors: Prevalence and associations with health-related quality of life. Support Care Cancer. 2018 Jun 27. doi10.1007/s00520-018-4317-8 [Epub ahead of print]

Zeissig SR, Weyer-Elberich V, Emrich K, Binder H, Fischbeck S, Imruck BH, Friedrich-Mai P, Beutel ME, Blettner M. Recruiting former melanoma patients via hospitals in comparison to office-based dermatologists in a register-based cohort study that required indirect contact. BMC Med Res Methodol. 2017;17(1):150. doi: 10.1186/s12874-017-0425-2.

Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; CONCORD Working Group; Africa. Erratum to "The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)". Gynecol Oncol. 2017 Dec;147(3):726.

Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD  Working Group. Erratum to "Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)". Gynecol Oncol. 2017 Dec;147(3):725.

Zeissig SR, Weyer-Elberich V, Emrich K, Binder H, Fischbeck S, Imruck BH, Friedrich-Mai P, Beutel ME, Blettner M. Recruiting former melanoma patients via hospitals in comparison to office-based dermatologists in a register-based cohort study that required indirect contact. BMC Med Res Methodol. 2017 Nov 22;17(1):150.

Singer S, Zeissig SR, Emrich K, Holleczek B, Kraywinkel K, Ressing M: Incidence of lip malignancies in Germany- data from 9 population-based cancer registries. J Oral Pathol Med 2017 Oct;46(9):780-785

Pulte D, Weberpals J, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H; GEKID Cancer Survival Working Group. Survival for patients with rare haematologic malignancies: Changes in the early 21st century.  Eur J Cancer. 2017 Oct;84:81-87.

Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, Piñeros M, Sant M, Kuehni CE, Murphy MFG, Coleman MP, Allemani C; CONCORD Working Group. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries. Lancet Haematol. 2017 May;4(5):e202-e217.

Paschold M, Huber T, Maedge S, Zeissig SR, Lang H, Kneist W. Laparoscopic assistance by operating room nurses: Results of a virtual-reality study. Nurse Educ Today. 51:68-72, Apr 2017.

Winter A, Sirri E, Jansen L, Wawroschek F, Kieschke J, Castro FA, Krilaviciute A, Holleczek B, Emrich K, Waldmann A, Brenner H, GEKID Cancer Survival Working Group. Comparison of prostate cancer survival in Germany and the United States: Can differences be attributed to differences in stage distributions? BJU Int. 119(4):550-559, Apr 2017.

Baras N, Dahm S, Haberland J, Janz M, Emrich K, Kraywinkel K, Salama, A: Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012). Br J Haematol. 2017 Apr;177(2):226-242.

Fischbeck S, Weyer-Elberich V, Zeissig SR, Imruck BH, Blettner M, Binder H, Beutel ME. Determinants of illness-specific social support and its relation to distress in long-term melanoma survivors.  BMC Public Health. 2018 Apr 17;18(1):511. doi: 10.1186/s12889-018-5401-1

Emrich K, Schmidtmann I, Zeissig SR, Blettner M. Statistische Methoden für Krebsregister. Onkologe 23:255-263, Mar 2017.

Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Scheufele R, Wirth MP, Huber J. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study. Prostate Cancer Prostatic Dis. 20(1):61-66, Mar 2017.

Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H. Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta Oncol. 56(2):190-197, Feb 2017.

Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V. Progredienzangst ≥5 Jahre nach Krebsdiagnose – Ergebnisse der krebsregisterbasierten, bevölkerungsbasierten CAESAR-Studie. Onkologe doi: 10.1007/s00761-017-0188-8 [Epub ahead of print], Feb 2017.  

Zeissig SR, Arndt V, Kraywinkel K. Neue Rubrik Epidemiologie. Onkologe 23: 89, Feb 2017.

Baras N, Dahm S, Haberland J, Janz M, Emrich K, Kraywinkel K, Salama, A. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012). Br J Haematol. doi: 10.1111/bjh.14530 [Epub ahead of print], Jan 2017.

Publikationen 2016

Zeitschriftenbeiträge (nach Erscheinungsdatum)

Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V. Fear of recurrence in long-term cancer survivors-Do cancer type, sex, time since diagnosis, and social support matter? Health Psychol. 35(12):1329-33, Dec 2016.

Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, Ressing M, Holleczek B, Luttmann S, Brenner H, GEKID Cancer Survival Working Group. Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults. Int J Cancer 139(6):1289-96, Sep 2016.

Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, Scheid C, Luttmann S, Emrich K, Holleczek B, Katalinic A, Nennecke A, Straka C, Langer C, Engelhardt M, Einsele H, Kröger N, Beelen D, Dreger P, Brenner H, Goldschmidt H, GEKID Cancer Survival Working Group and the DRST. Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation. Eur J Cancer 62:1-8, Jul 2016.

Sirri E, Castro FA, Kieschke J, Jansen L, Emrich K, Gondos A, Holleczek B, Katalinic A, Urbschat I, Vohmann C, Brenner H. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States. Pancreas 45(6):908-14, Jul 2016.

Becker C, Blettner M, Kaatsch P, Ressing M, Zeißig S. Welche Daten zu Krebs und zur Mortalität findet man in Deutschland? Strahlenschutz Praxis 2/2016: 34-38, Apr 2016.

Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, Zeissig SR, Brenner H, Katalinic A, GEKID Cancer Survival Working Group. Survival from non-melanoma skin cancer in Germany. Br J Dermatol. 174(4):778-85, Apr 2016.

Pulte D, Castro FA, Jansen L, Luttmann S, Holleczek B, Nennecke A, Ressing M, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century. J Hematol Oncol. 9:28, Mar 2016.

Chen T, Fallah M, Brenner H, Jansen L, Mai EK, Castro FA, Katalinic A, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist K, Hemminki K, GEKID Cancer Survival Working Group. Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries. Sci Rep. 6:22084. doi: 10.1038/srep22084. Feb 2016.

Bayer O, Camará R, Zeissig SR, Ressing M, Dietz A, Locati L, Ramroth H, Singer S: Occupation and cancer of the larynx – a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 273(1):9-20, Jan 2016.

Brenner H, Castro FA, Eberle A, Emrich K, Holleczek B, Katalinic A, Jansen L, GEKID Cancer Survival Workgroup. Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time. Eur J Cancer. 52:102-8, Jan 2016.

Buchbeiträge

Zeissig SR, Blettner M. Krebsepidemiologie in Deutschland. In: Handbuch Psychoonkologie. Mehnert A, Koch U (Hrsg.). Hogrefe Verlag. 1. Auflage 2016. ISBN 978-3-8017-2474-0

Vorträge auf Tagungen

•    Kongress der Deutschen Gesellschaft für Chirurgie, Berlin, Germany, 26.-29. April 2016:  Paschold M, Huber T, Mägde S, Zeissig S, Lang H, Kneist W. Laparoskopische Fertigkeiten am virtuellen Laparoskopiesimulator – Leistungserfassung einer chirurgischen Klinik. 133. DOI: 10.3205/16dgch058 [Vortrag] 

•    European Cancer Rehabilitation Survivorship Symposium, 19.-20. September 2016, Copenhagen: Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Hermann Brenner. Quality of life in long-term and very long-term cancer survivors versus population controls in Germany [Vortrag]

•    38th International Association of Cancer Registries – Scientific Conference, 19.-21. Oktober 2016, Marrakech, Marocco:  Zeissig SR, Wardelmann E, Blettner M, Emrich K, Hohenberger P, Jakob J, Kasper B, Ressing M. Health data on rare and heterogeneous diseases: Incidence of sarcomas and histological subtypes in Germany [Vortrag]

•    Scientific Meeting des ENCR (European Network for Cancer Registries), 05.-07. Oktober 2016, Baveno, Italy: Emrich K, Seebauer G. Comparison of the old method of record linkage with the new “system, break free” method at the Cancer Registry Rhineland-Palatinate [Vortrag]

•    HEC 2016, Health-Exploring complexity; GMDS & DGEpi & IEA-EEF annual meeting, Medical Informatics Europe – MIE 2016, 28. August - 02. September 2016, Munich, Germany: Emrich K, Seebauer G. Goldstandardvergleich eines neuen Verfahrens zum Record-Linkage des Krebsregisters Rheinland-Pfalz [Vortrag]

Poster auf Tagungen

•    32. Deutscher Krebskongress, 24.-27.Februar 2016, Berlin:
 Ressing M, Wardelmann E, Blettner M, Emrich K, Hohenberger P, Jakob J, Kasper B, Zeissig SR. Incidence of sarcomas and histological subtypes in Germany [Poster]             
                                
Fiebig J, Kraywinkel K, Castro F, Jansen L, Zeißig SR, Luttmann S, Katalinic A, Holleczek B, Brenner H. Survival of non-muscle-invasive bladder cancer in Germany by tumor stage and grade [Poster]

•    HEC 2016, Health-Exploring complexity; GMDS & DGEpi & IEA-EEF annual meeting, Medical Informatics Europe – MIE 2016, 28. August - 02. September 2016, München:

Brunssen A, Jansen L, Eisemann N, Waldmann A, Kraywinkel K, Eberle A, Holleczek B, Zeissig SR, Brenner H, Katalinic A. Relative survival from melanoma stratified by tumor stage and histological subtype [Poster]

•    European Cancer Rehabilitation Survivorship Symposium, 19.-20. September 2016, Copenhagen
Arndt V, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H. Rationale, design and implementation of the CAESAR study - a multiregional, large-scale population-based study on long-term cancer survivors [Poster]

•    Scientific Meeting des ENCR (European Network for Cancer Registries), 05.-07. Oktober 2016, Baveno

Ressing M, Zeissig SR, Emrich K, Holleczek B, Kraywinkel K, Mischkowski R, Schulze H-J, Singer S.  Incidence of lip malignancies in Germany – data from 9 population-based cancer registries [Poster]

•    Annual Meeting of the Connective Tissue Oncology Society (ctos), 09.-12. November 2016, Lissabon
Ressing M, Wardelmann E., Hohenberger P, Jakob J, Kasper B, Emrich K, Eberle A, Blettner M, Zeissig S. Incidence of sarcomas and histological subtypes in Germany – First national survey [Poster]

Publikationen 2015

Zeitschriftenbeiträge (nach Erscheinungsdatum)

Chen T, Fallah M, Jansen L, Castro FA, Krilavicuite A, Katalinic A, Eisemann N, Emrich K, Holleczek B, Geiss K, Eberle A, Sundquist J, Brenner H, Hemminki K, GEKID Cancer Survival Working Group. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. Cancer Lett. 369(1):152-66, Dec 2015.

Eberle A, Jansen L, Castro F, Krilaviciute A, Luttmann S, Emrich K, Holleczek B, Nennecke A, Katalinic A, Brenner H, GEKID Survival Working Group. Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients. Lung Cancer 90(3):528-33, Dec 2015.

Castro FA, Jansen L, Krilaviciute A, Katalinic A, Pulte D, Sirri E, Ressing M, Holleczek B, Luttmann S, Brenner H, GEKID Cancer Survival Working Group. Survival of patients with gastric lymphoma in Germany and in the United States. J Gastroenterol Hepatol. 30(10):1485-91, Oct 2015.

Pulte D, Jansen L, Castro FA, Emrich K, Katalinic A, Holleczek B, Brenner H, GEKID Cancer Survival Working Group. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century. Br J Haematol. 171(2):189-96, Oct 2015.

Fischbeck S, Imruck BH, Blettner M, Weyer V, Binder H, Zeissig SR, Emrich K, Friedrich-Mai P, Beutel ME. Psychosocial Care Needs of Melanoma Survivors: Are They Being Met? PLoS One. 10(8): e0132754, Aug 2015.

Zeissig SR, Singer S, Koch L, Zeeb H, Merbach M, Bertram H, Eberle A, Schmid-Höpfner S, Holleczek B, Waldmann A, Arndt V. Utilisation of psychococial and informational services in immigrant and non-immigrant German cancer survivors. Psychooncology 24 (8): 919–25, Aug 2015.

Bayer O, Krüger M, Koutsimpelas M, Ressing M, Emrich K, Zeissig SR, Singer S. [Changes in Incidence and Mortality Trends of Head and Neck Cancer in Rhineland-Palatinate, 2000-2009] [Veränderung von Inzidenz und Mortalität von Kopf-Hals-Malignomen in Rheinland-Pfalz in 2000-2009]. Laryngorhinootologie 94(7):451-8, Jul 2015.

Hammer GP, Emrich K, Nasterlack M, Blettner M, Yong M. Shift Work and Prostate Cancer Incidence in Industrial Workers: A Historical Cohort Study in a German Chemical Company. Dtsch Arztebl Int. 112(27-28):463-70, Jul 2015.

Jansen L, Castro FA, Gondos A, Krilaviciute A, Barnes B, Eberle A, Emrich K, Hentschel S, Holleczek B, Katalinic A, Brenner H, GEKID Cancer Survival Working Group. Recent cancer survival in Germany: an analysis of common and less common cancers. Int J Cancer 136(11):2649-58, Jun 2015.

Zeissig SR, Singer S, Koch L, Blettner M, Brenner H, Arndt V, CAESAR Studiengruppe. Inanspruchnahme psychoonkologischer Versorgung im Krankenhaus und in Krebsberatungsstellen durch Brust-, Darm- und Prostatakrebsüberlebende [Utilisation of Psycho-oncological Services in Hospitals and Outpatient Counselling Centres by Survivors of Breast, Colon and Prostate Cancer]. Psychother Psychosom Med Psychol. 65(5):177-82, May 2015.

Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Stabenow R, Fröhner M, Huber J. Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011. Radiother Oncol. 115(1):90-5, Apr 2015.

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, … Coleman MP, CONCORD Working Group. Global surveillance of cancer survival 1995–2009: analysis of individual data for    25. 676.887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 385(9972):977-1010, Mar 2015.
Beutel ME, Fischbeck S, Binder H, Blettner M, Brähler E, Emrich K, Friedrich-Mai P, Imruck BH, Weyer V, Zeissig SR. Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study. PLoS One. 10(1):e0116440, Jan 2015.

Vorträge auf Tagungen

•    Sarkomkonferenz, Münster/Westfalen, 26.-28. Februar 2015: Zeißig S. Epidemiologie von Sarkomen

•    8. Gesundheitspolitischer Impuls Rheinland-Pfalz: Zukunft der onkologischen Therapie -Optimale Versorgung des Krebspatienten, 11. März 2015, Mainz: Zeißig S. Krebsregistrierung in Rheinland-Pfalz : Daten für Taten

•    21. Informationstagung Tumordokumentation, Stuttgart, 22.-24. April 2015: Zeissig SR, Jahn K. Krebsregister Rheinland-Pfalz gGmbH: Strukturmodell eines integrierten klinisch-epidemiologischen Krebsregisters

•    10. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi), Potsdam,            29. September -02. Oktober 2015:

Fick E-M, Waldmann A, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Katalinic A, Schmid-Höpfner S, Zeissig SR, Brenner H, Arndt V. Long-term (≥ 5 years) cancer survivors – still cancer patients? – Results from the German CAESAR-study. [Vortrag]

Radde K, Bussas U, Gottschalk A, Schülein S, Schriefer D, Seifert U, Zeissig SR, Kaiser M, Blettner M, Klug SJ. Verteilung der HPV-Typen in einer populationsbezogenen Stichprobe von Frauen ab 30 Jahren in Deutschland vor Einführung der HPV-Impfung [Vortrag]

Bredehöft M, Fick E-M, Waldmann A, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Zeissig SR, Brenner H, Arndt V. Psychosoziale Belastung bei Langzeitüberlebenden einer Brustkrebserkrankung – Ergebnisse aus der multizentrischen, populationsbezogenen CAESAR-Studie [Vortrag]

Bredehöft M, Fick E-M, Waldmann A, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Zeissig SR, Brenner H, Arndt V. Soziale Isolation und Lebensqualität bei Langzeitüberlebenden einer Brustkrebserkrankung – Ergebnisse aus der multizentrischen, populationsbezogenen CAESAR-Studie [Vortrag]

Arndt V, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H. Comparison of response waves to estimate non-response bias in a postal survey among long-term cancer survivors [Vortrag]

•    60. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (gmds), Krefeld, 06.-09.09.2016: Zeissig SR, Weyer V, Emrich K, Fischbeck S, Imruck BH, Friedrich-Mai P, Beutel ME, Blettner M, Binder H. No evidence of two distinct types of selection bias in physician-mediated long-term follow-up of malignant melanoma patients [Vortrag]

Poster auf Tagungen

•    10. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi), Potsdam, 29.September - 02.Oktober 2015:

Ressing M, Zeißig S, Leischner S, Klissenbauer M, Blettner M. Vergleich der Kodierung von Krebserkrankungen auf Totenscheinen im Rahmen des landesweiten Mortalitätsregisters Rheinland-Pfalz [Poster]

Radde K, Schriefer D, Schoffer O, Bussas U, Zeissig SR, Kaiser M, Ikenberg H, Schwarzer K, Einzmann T, Kölbl H, Blettner M, Klug, SJ. Vergleich der Validität von Zytologie und HPV-Tests zur Detektion zervikaler intraepithelialer Neoplasien: eine randomisierte bevölkerungsbezogene Studie [Poster]

•    22. Jahrestagung der International Society for Quality of Life Research (ISOQOL), Vancouver, 21.-24. Oktober 2015: Waldmann A, Bredehöft M, Koch-Gallenkamp L, Bertram H, Eberel A, Holleczek B, Schmid-Höpfner S, Zeissig SR, Brenner H, Arndt V. Social support is associated with mental health and health-related quality of life in breast cancer survivors – results from the German population-based, multiregional CAESAR-Study [Poster]

•    30th Anniversary European Association of Urology Congress, Madrid, 20.-24. März 2015: Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, Fröhner M, Wirth MP, Huber J. Radiotherapy is the preferred treatment for locally advanced prostate cancer in the USA while radical prostatectomy dominates in Germany: A comparative population-based study [Poster]

•    70. Jahrestagung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten mit Sektion Endoskopie – 9. Herbsttagung der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie gemeinsam mit den Arbeitsgemeinschaften der DGAV, 16.-19. September 2015, Leipzig: Paschold M, Huber T, Mädge S, Zeissig S, Lang H, Kneist W. PJ-Studierende und OP-Pflegepersonal am Laparoskopiesimulator – Eine Leistungsanalyse [Poster]